Concerning IP3R3 subtype, it appears as a key actor of carcinogenesis as its expression level is correlated with colorectal carcinoma aggressiveness [22], whereas its inhibition reduces breast cancer cell proliferation [17], migration, invasion and survival of glioblastoma cells [20]. Here, ITPR3 is linked to breast cancer.